Development and validation of a novel LC–MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column-Reference-Cited by-同舟云学术

Development and validation of a novel LC–MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column

Published:2017-09 Issue: Volume:172 Page:231-239
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Alyamani Mohammad,Li Zhenfei,Upadhyay Sunil K.,Anderson David J.,Auchus Richard J.,Sharifi Nima

Funder

Howard Hughes Medical Institute Physician-Scientist Early Career Award

National Cancer Institute

US Army Medical Research and Materiel Command

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference22 articles.

1. Prostate cancer;Attard;Lancet (London, England),2016

2. Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer;Miyamoto;Cancer Discov.,2012

3. Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene;Deslypere;Mol. Cell. Endocrinol.,1992

4. Androgen deprivation therapy for prostate cancer;Sharifi;JAMA,2005

5. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group;Scher;J. Clin. Oncol.,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of novel phenylalanine-coated copper nanoclusters for fluorescent probes to determine the interactions of cancer drugs with DNA;Journal of Pharmaceutical and Biomedical Analysis;2024-10

2. The first RP-UHPLC method for simultaneous quantification of abiraterone acetate, its four degradants, and six specified process impurities and correct identification of all analytes based on molecular weight;Journal of Pharmaceutical and Biomedical Analysis;2023-09

3. Validation of an LC-MS/MS method for simultaneous quantification of abiraterone, enzalutamide and darolutamide in human plasma;Journal of Chromatography B;2023-06

4. Impact of trough abiraterone level on adverse events in patients with prostate cancer treated with abiraterone acetate;European Journal of Clinical Pharmacology;2022-11-15

5. Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer;Medical Science Monitor;2022-09-30